Investec Bank Plc has filed a Form 8.5 public dealing disclosure relating to its trading activity in Advanced Medical Solutions Group Plc ordinary shares.
The disclosure, filed on 10th August 2026, covers dealing activity that took place on 7th August 2026 under Rule 8.5 of the Takeover Code.
Investec Bank Plc is identified in the filing as an exempt principal trader acting in a client-serving capacity with recognised intermediary status.
The bank serves as Advisor and Joint Broker to Advanced Medical Solutions Group Plc, establishing its connected status to the offer party named in the disclosure.
During the dealing period, Investec purchased 9,541 ordinary shares in Advanced Medical Solutions Group at a price of 281.25 pence per unit.
On the sales side, the bank disposed of 147,431 ordinary shares, with prices ranging between 281 pence and 281.25 pence per unit.
The volume of shares sold significantly outweighed purchases, with over 147,000 ordinary shares changing hands on the sell side alone.
The filing confirms that no cash-settled derivative transactions, stock-settled derivatives, or options were executed during the relevant dealing period.
Investec also confirmed there are no indemnity arrangements, option agreements, or understandings that may constitute an inducement to deal or refrain from dealing.
The bank further confirmed no agreements or understandings exist relating to voting rights or the future acquisition or disposal of securities referenced by any derivative instrument.
Contact for the disclosure was listed as Abhishek Gawde, reachable by telephone, with the filing submitted in accordance with regulatory requirements under the Takeover Code.
Public disclosures under Rule 8 of the Code are required to be made to a Regulatory Information Service, with oversight provided by the Panel’s Market Surveillance Unit.
